PSGL-1

PSGL-1

PSGL-1 Overview

Molecule Name
P-selectin glycoprotein ligand-1
Synonyms
PSGL1,CD162,SELPLG,Selectin P ligand
Drug Development Progress
Drugs in Clinical Trials4
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
P-selectin glycoprotein ligand 1,PSGL-1,SELPLG,Selectin P Ligand,Cutaneous Lymphocyte-Associated Associated Antigen,CD162 Antigen,CD162,PSGL1,CLA
Background
P-selectin glycoprotein ligand 1 (PSGL-1) is also known as Selectin P ligand (SELPLG), CD antigen CD162. PSGL-1 is disulfide-linked homodimer which is the high affinitycounter-receptor for P-selectin on expressed on activated endothelial cells and platelets. PSGL-1 / SELPLG interacts with P-, E- and L-selectins, through their lectin/EGF domains, is required for promoting recruitment and rolling of leukocytes. These interactions require sialyl Lewis X glycan modification but there is a differing dependence for tyrosine sulfations. Dimerization appears not to be required for P-selectin/SELP binding. PSGL-1 can interact with SNX20, MSN and SYK. PSGL-1 / SELPLG mediate the activation of SYK by SELPLG.

PSGL-1 Product List

Species
  • Human(2)
Tag
  • His Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(2)
Conjugate
  • Biotin-labeled(1)
  • Unconjugated(1)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
PSGL-1
Human PSGL-1 / CD162 Protein, His Tag
Human
HEK293
SDS-PAGE
SPR

$395.00

100ug
PSGL-1
Avitag
PS1-H82E4
Biotinylated Human PSGL-1 / CD162 Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
CepeprubartSelK-2Phase 2 ClinicalSelexys
Asthma; Pulmonary Disease, Chronic Obstructive; Venous Thromboembolism
Details
LeiolizumabAbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268Phase 2 ClinicalAltrubio Inc
Arthritis, Psoriatic; Colitis, Ulcerative
Details
NeihulizumabAbGn-168; AbGn-168H; ALTB-168Phase 1 ClinicalAltrubio Inc
Arthritis, Psoriatic; Colitis, Ulcerative; Graft vs Host Disease; Plaque psoriasis; Psoriasis
Details
SSGJ-617SSGJ-617; SSGJ617; 61X; VTX-0811; 617Phase 1 ClinicalVerseau Therapeutics Inc
Solid tumours
Details
Customer Reviews